Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LF3 是一种典型 Wnt 信号传导的特异性抑制剂,通过破坏 β-catenin 和 TCF4 之间的相互作用(IC50 < 2 μM)
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 268 | 现货 | ||
5 mg | ¥ 453 | 现货 | ||
10 mg | ¥ 653 | 现货 | ||
25 mg | ¥ 1,280 | 现货 | ||
50 mg | ¥ 2,360 | 现货 | ||
100 mg | ¥ 3,480 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 553 | 现货 |
产品描述 | LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM) |
靶点活性 | β-catenin/TCF4 (Alpha Screen):1.65 μM , β-catenin/TCF4 (ELISA):1.82 μM |
体外活性 | LF3 inhibited Wnt/β-catenin signals in cells with exogenous reporters and in colon cancer cells with endogenously high Wnt activity. LF3 also suppressed features of cancer cells related to Wnt signaling, including high cell motility, cell-cycle progression, and the overexpression of Wnt target genes[1]. |
体内活性 | LF3 reduced tumor growth and induced differentiation in a mouse xenograft model of colon cancer.LF3 is a specific inhibitor of canonical Wnt signaling with anticancer activity[1]. |
动物实验 | Unsorted GFPlow and GFPhigh SW480 cells (1 × 10^4) were subcutaneously injected into the back skin of NOD/SCID mice. Tumor growth was monitored over a period of 45 days. For therapy, LF3 was administered i.v. at 50 mg/kg body weight for three rounds over 5 consecutive days, with 2-day breaks[1]. |
分子量 | 416.56 |
分子式 | C20H24N4O2S2 |
CAS No. | 664969-54-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (76.82 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4006 mL | 12.0031 mL | 24.0061 mL | 60.0154 mL |
5 mM | 0.4801 mL | 2.4006 mL | 4.8012 mL | 12.0031 mL | |
10 mM | 0.2401 mL | 1.2003 mL | 2.4006 mL | 6.0015 mL | |
20 mM | 0.12 mL | 0.6002 mL | 1.2003 mL | 3.0008 mL | |
50 mM | 0.048 mL | 0.2401 mL | 0.4801 mL | 1.2003 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
LF3 664969-54-4 Cytoskeletal Signaling Stem Cells Wnt/beta-catenin β-catenin Beta catenin LF 3 LF-3 inhibit Inhibitor inhibitor